Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

283 trials

NCT04545762
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 1 · United States · 1 site
Registry update: 26 Oct 2026
NCT04332822
Recruiting
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Phase 3 · Australia, Denmark, Estonia, Finland, Italy, Norway, New Zealand, Sweden · 71 sites
Registry update: 19 Sept 2024
Conflicting statuses (not updated in the registry for 25 months)
NCT04186520
Recruiting
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Phase 1/2 · United States · 1 site
Registry update: 23 Feb 2026
NCT04300101
Recruiting
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
Not applicable · Italy · 4 sites
Registry update: 10 Apr 2025
NCT03936153
Recruiting
Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Phase 2 · China · 23 sites
Registry update: 10 Apr 2025
NCT04094311
Recruiting
Study of Out of Specification for Tisagenlecleucel
Phase 3 · Canada, Japan · 44 sites
Registry update: 15 Sept 2026
NCT04104776
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Phase 1/2 · Spain, France, United Kingdom, Italy, South Korea, Poland, United States · 76 sites
Registry update: 19 Aug 2026
NCT04002947
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Phase 2 · United States · 1 site
Registry update: 9 Nov 2026
NCT03930953
Recruiting
An early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
Phase 1/2 · Denmark, Spain, France, Italy · 21 sites
Registry update: 11 Nov 2026
NCT03758989
Recruiting
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
Phase 2 · United States · 1 site
Registry update: 13 Oct 2026
NCT03676504
Recruiting
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Phase 1/2 · Germany · 1 site
Registry update: 29 Jul 2024
NCT03460977
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Phase 1 · Bulgaria, China, Spain, Japan, South Korea, Poland, Russia, United States · 87 sites
Registry update: 15 Oct 2026
NCT03501576
Recruiting
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Not applicable · United States · 2 sites
Registry update: 6 Jul 2026
NCT03418038
Recruiting
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Phase 2 · United States · 4 sites
Registry update: 28 Sept 2026
NCT03356054
Recruiting
Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse
Phase 1/2 · Belgium, Spain, Netherlands · 16 sites
Registry update: 10 Dec 2020
Conflicting statuses (not updated in the registry for 71 months)
NCT03223610
Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Phase 1/2 · United States · 1 site
Registry update: 9 Nov 2026
NCT03375619
Recruiting
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Not applicable · United States · 1 site
Registry update: 10 Nov 2025
NCT03280394
Recruiting
Liquid Biopsy in Mature B-cell Tumors
Not applicable · Switzerland · 1 site
Registry update: 9 Jul 2026
NCT03125642
Recruiting
Auto Stem Cell Transplant for Lymphoma Patients
Phase 2 · United States · 1 site
Registry update: 4 Nov 2026
NCT02964858
Recruiting
Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.
Not applicable · India · 1 site
Registry update: 11 Apr 2025

Ordered by registry start date. Freshness and sponsorship never change the order.